Filing Details
- Accession Number:
- 0001225208-14-025386
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-17 18:15:25
- Reporting Period:
- 2014-12-15
- Filing Date:
- 2014-12-17
- Accepted Time:
- 2014-12-17 18:15:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204663 | H John Weiland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | President And Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-15 | 13,589 | $84.58 | 115,785 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-15 | 1,750 | $165.10 | 114,035 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 1,821 | $167.96 | 112,214 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 2,810 | $167.30 | 109,404 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 7,208 | $166.27 | 102,196 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 9,206 | $166.63 | 92,990 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-12-16 | 131 | $167.92 | 92,859 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-16 | 3,457 | $166.23 | 89,402 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-16 | 5,916 | $167.44 | 83,486 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2014-12-15 | 13,589 | $0.00 | 13,589 | $84.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,590 | 2021-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,713 | Indirect | 401(k) Plan |
Footnotes
- Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $164.57 to $165.56. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $167.72 to $168.18. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $166.689 to $167.68. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $165.66 to $166.6358. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Shares withheld to pay taxes upon vesting of restricted stock units granted under the Company's 2003 Long Term Incentive Plan.
- Represents the weighted average sales price for price increments ranging from $167.88 to $167.93. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $165.72 to $166.50. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $166.88 to $167.87. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Of this option grant 13,589 options are fully vested, and the remaining 13,590 options vest on December 14, 2015.
Billionaire Hedge Funds
